PAM
KPTI icon

Panagora Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History

Panagora Asset Management’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,328
Closed -$347K – 1248
2024
Q1 		$347K Buy
15,328
+165
+1% +$2.89K ﹤0.01% 1045
2023
Q4 		$197K Buy
+15,163
New +$204K ﹤0.01% 1183
2021
Q1 		– Sell
-3,450
Closed -$801K – 2870
2020
Q4 		$801K Hold
3,450
– – ﹤0.01% 1057
2020
Q3 		$756K Hold
3,450
– – ﹤0.01% 999
2020
Q2 		$980K Sell
3,450
-2,644
-43% -$782K 0.01% 942
2020
Q1 		$1.76M Buy
+6,094
New +$1.68M 0.01% 631
2019
Q1 		– Sell
-6,728
Closed -$946K – 2536
2018
Q4 		$946K Sell
6,728
-283
-4% -$47.7K ﹤0.01% 1100
2018
Q3 		$1.79M Sell
7,011
-8,503
-55% -$2.35M 0.01% 882
2018
Q2 		$3.95M Buy
15,514
+5,513
+55% +$1.36M 0.02% 617
2018
Q1 		$2.01M Buy
10,001
+206
+2% +$41.1K 0.01% 872
2017
Q4 		$1.41M Buy
9,795
+4,575
+88% +$735K 0.01% 1017
2017
Q3 		$860K Buy
5,220
+1,112
+27% +$159K ﹤0.01% 1179
2017
Q2 		$558K Buy
+4,108
New +$608K ﹤0.01% 1316
2016
Q1 		– Sell
-121
Closed -$24K – 2316
2015
Q4 		$24K Sell
121
-31
-20% -$6.71K ﹤0.01% 2120
2015
Q3 		$24K Buy
+152
New +$40.7K ﹤0.01% 2114
2014
Q4 		– Sell
-62
Closed -$32K – 2314
2014
Q3 		$32K Hold
62
– – ﹤0.01% 2097
2014
Q2 		$43K Sell
62
-3
-5% -$1.4K ﹤0.01% 2127
2014
Q1 		$30K Buy
+65
New +$32.9K ﹤0.01% 2171

Other funds holding KPTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Panagora Asset Management's KPTI Position: Q2 2024 in Review

Panagora Asset Management sold out of Karyopharm Therapeutics (KPTI) in Q2 2024, closing a stake of 15,328 shares — an estimated $347K sold.

Panagora Asset Management first reported a position in KPTI in Q1 2014 and held it in 18 quarters. The position peaked at $3.95M in Q2 2018. 114 funds tracked by Wall St. Rank hold KPTI as of Q2 2024.

  • Panagora Asset Management reported no remaining Karyopharm Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Panagora Asset Management sold 15,328 Karyopharm Therapeutics shares in Q2 2024, an estimated $347K.
  • Panagora Asset Management first reported a position in Karyopharm Therapeutics in Q1 2014 and held it in 18 quarters.
  • Panagora Asset Management's Karyopharm Therapeutics position peaked at $3.95M in Q2 2018.
  • 114 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2024.

Based on Panagora Asset Management's 13F filing for Q2 2024, filed 29 Jul 2024.